Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Executive Officer

Chief Business Officer

Chief Financial Officer

Chief Medical Officer

Chief Scientific Officer

General Counsel & Corp. Sec.

Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases through virus-like particle (VLP) platform technology. Its lead product candidate IVX-A12, a respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) VLP vaccine. The company also develops IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; and IVX-241, a vaccine candidate with hMPV target. Icosavax, Inc. was incorporated in 2017 and is headquartered in Seattle, Washington.

Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases through virus-like particle (VLP) platform tech...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-02-19	Premium	sold	Premium	Premium	Premium	-
2024-02-19	Premium	sold	Premium	Premium	Premium	-
2024-02-19	Premium	sold	Premium	Premium	Premium	-
2024-02-19	Premium	sold	Premium	Premium	Premium	-
2024-02-19	Premium	back to issuer	Premium	Premium	Premium	-
2024-02-19	Premium	sold	Premium	Premium	Premium	-
2024-02-19	Premium	sold	Premium	Premium	Premium	-
2024-02-19	Premium	back to issuer	Premium	Premium	Premium	-
2024-02-19	Premium	sold	Premium	Premium	Premium	-
2024-02-19	Premium	back to issuer	Premium	Premium	Premium	-
2024-02-19	Premium	sold	Premium	Premium	Premium	-
2024-02-19	Premium	back to issuer	Premium	Premium	Premium	-
2024-02-19	Premium	sold	Premium	Premium	Premium	-
2024-02-19	Premium	sold	Premium	Premium	Premium	-
2024-02-19	Premium	sold	Premium	Premium	Premium	-
2024-02-19	Premium	sold	Premium	Premium	Premium	-
2024-02-01	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2024-02-01	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2024-02-01	Premium	gifted	Premium	Premium	Premium	Chief Executive Officer
2024-01-22	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2024-01-02	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2024-01-02	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2023-12-21	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2023-12-21	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-12-20	Premium	sold	Premium	Premium	Premium	Chief Business Officer

ICVX - Icosavax, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for ICVX